Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 583262, 10 pages
http://dx.doi.org/10.1155/2015/583262
Review Article

Overview of the Diagnostic Methods Used in the Field for Human African Trypanosomiasis: What Could Change in the Next Years?

1INSERM, U1094, Tropical Neuroepidemiology, Limoges, France
2UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, Université de Limoges, CNRS FR 3503 GEIST, 87000 Limoges, France

Received 12 March 2015; Revised 19 June 2015; Accepted 2 July 2015

Academic Editor: Stephan Karl

Copyright © 2015 Julien Bonnet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Brun, J. Blum, F. Chappuis, and C. Burri, “Human African trypanosomiasis,” The Lancet, vol. 375, no. 9709, pp. 148–159, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. T. N. Baral, “Immunobiology of African trypanosomes: need of alternative interventions,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 389153, 24 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Sternberg and L. Maclean, “A spectrum of disease in Human African trypanosomiasis: the host and parasite genetics of virulence,” Parasitology, vol. 137, no. 14, pp. 2007–2015, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. Franco, P. P. Simarro, A. Diarra, and J. G. Jannin, “Epidemiology of human African trypanosomiasis,” Clinical Epidemiology, vol. 6, no. 1, pp. 257–275, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Aksoy, A. Caccone, A. P. Galvani, and L. M. Okedi, “Glossina fuscipes populations provide insights for human African trypanosomiasis transmission in Uganda,” Trends in Parasitology, vol. 29, no. 8, pp. 394–406, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. WHO, “Control and surveillance of human African trypanosomiasis,” Report of a WHO Expert Committee 984, WHO, 2013. View at Google Scholar
  7. P. P. Simarro, A. Diarra, J. A. R. Postigo, J. R. Franco, and J. G. Jannin, “The human African trypanosomiasis control and surveillance programme of the world health organization 2000–2009: the way forward,” PLoS Neglected Tropical Diseases, vol. 5, no. 2, Article ID e1007, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Ripert, “Epidémiologie des maladies parasitaires, protozooses et helminthoses réservoirs, vecteurs et transmission,” Editions Médicales Internationales, vol. 1, 1996. View at Google Scholar
  9. M. Gentilini and B. Duflo, Médecine Tropicale, Flammarion, 4th edition, 1986.
  10. J. Pépin and H. Méda, “The epidemiology and control of human African trypanosomiasis,” Advances in Parasitology, vol. 49, pp. 71–132, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Checchi, J. A. N. Filipe, D. T. Haydon, D. Chandramohan, and F. Chappuis, “Estimates of the duration of the early and late stage of gambiense sleeping sickness,” BMC Infectious Diseases, vol. 8, article 16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Burri, “Chemotherapy against human African trypanosomiasis: is there a road to success?” Parasitology, vol. 137, no. 14, pp. 1987–1994, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. G. N. Sekhar, C. P. Watson, M. Fidanboylu, L. Sanderson, and S. A. Thomas, “Delivery of antihuman African trypanosomiasis drugs across the blood-brain and blood-CSF barriers,” Advances in Pharmacology, vol. 71, pp. 245–275, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. P. G. E. Kennedy, “Human African trypanosomiasis of the CNS: current issues and challenges,” The Journal of Clinical Investigation, vol. 113, no. 4, pp. 496–504, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Priotto, L. Pinoges, I. B. Fursa et al., “Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study,” British Medical Journal, vol. 336, no. 7646, pp. 705–708, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. J. C. Munday, A. A. Eze, N. Baker et al., “Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs,” Journal of Antimicrobial Chemotherapy, vol. 69, no. 3, Article ID dkt442, pp. 651–663, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Torreele, B. Bourdin Trunz, D. Tweats et al., “Fexinidazole: a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness,” PLoS Neglected Tropical Diseases, vol. 4, no. 12, article e923, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Eperon, M. Balasegaram, J. Potet, C. Mowbray, O. Valverde, and F. Chappuis, “Treatment options for second-stage gambiense human African trypanosomiasis,” Expert Review of Anti-Infective Therapy, vol. 12, no. 11, pp. 1407–1417, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Tarral, S. Blesson, O. V. Mordt et al., “Determination of an optimal dosing regimen for Fexinidazole, a novel oral drug for the treatment of Human African trypanosomiasis: first-in-human studies,” Clinical Pharmacokinetics, vol. 53, no. 6, pp. 565–580, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. R. T. Jacobs, B. Nare, S. A. Wring et al., “SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human african trypanosomiasis,” PLoS Neglected Tropical Diseases, vol. 5, no. 6, Article ID e1151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Penchenier, P. Grébaut, F. Njokou, V. Eboo Eyenga, and P. Büscher, “Evaluation of LATEX/T.b.gambiense for mass screening of Trypanosoma brucei gambiensesleeping sickness in Central Africa,” Acta Tropica, vol. 85, no. 1, pp. 31–37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. A. K. Ebeja, “Journée scientifique THA à Kinshasa. Bulletin HAT Platform,” 2013, http://www.dndi.org/images/stories/strengthening_capacities/newsletter.final.ENGLISH.THA12.pdf.
  23. F. Checchi, F. Chappuis, U. Karunakara, G. Priotto, and D. Chandramohan, “Accuracy of five algorithms to diagnose gambiense human african trypanosomiasis,” PLoS Neglected Tropical Diseases, vol. 5, no. 7, Article ID e1233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Dukes, W. C. Gibson, J. K. Gashumba et al., “Absence of the LiTat 1.3 (CATT antigen) gene in Trypanosoma brucei gambiense stocks from Cameroon,” Acta Tropica, vol. 51, no. 2, pp. 123–134, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Edeghere, P. O. Olise, and D. S. Olatunde, “Human African trypanosomiasis (sleeping sickness): new endemic foci in Bendel State, Nigeria,” Tropical Medicine and Parasitology, vol. 40, no. 1, pp. 16–20, 1989. View at Google Scholar · View at Scopus
  26. W. O. Inojosa, I. Augusto, Z. Bisoffi et al., “Diagnosing human African trypanosomiasis in Angola using card agglutination test: observational study of active and passive case finding strategies,” The British Medical Journal, vol. 332, no. 7556, pp. 1479–1483, 2006. View at Publisher · View at Google Scholar
  27. F. Chappuis, E. Stivanello, K. Adams, S. Kidane, A. Pittet, and P. A. Bovier, “Card agglutination test for trypanosomiasis (CATT) end-dilution titer and cerebrospinal fluid cell count as predictors of human African trypanosomiasis (Trypanosoma brucei gambiense) among serologically suspected individuals in Southern Sudan,” The American Journal of Tropical Medicine and Hygiene, vol. 71, no. 3, pp. 313–317, 2004. View at Google Scholar · View at Scopus
  28. P. P. Simarro, J. A. Ruiz, J. R. Franco, and T. Josenando, “Attitude towards CATT-positive individuals without parasitological confirmation in the African trypanosomiasis (T.b. gambiense) focus of Quicama (Angola),” Tropical Medicine and International Health, vol. 4, no. 12, pp. 858–861, 1999. View at Google Scholar · View at Scopus
  29. P. Lutumba, J. Robays, C. Miaka et al., “Validity, cost and feasibility of the mAECT and CTC confirmation tests after diagnosis of African of sleeping sickness,” Tropical Medicine and International Health, vol. 11, pp. 470–478, 2006. View at Google Scholar
  30. P. Büscher, D. M. Ngoyi, J. Kaboré et al., “Improved models of mini anion exchange centrifugation technique (mAECT) and modified single centrifugation (MSC) for sleeping sickness diagnosis and staging,” PLoS Neglected Tropical Diseases, vol. 3, no. 11, article e471, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Bisser, V. Lejon, P. M. Preux et al., “Blood-cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness,” Journal of the Neurological Sciences, vol. 193, no. 2, pp. 127–135, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Buguet, S. Bisser, T. Josenando, F. Chapotot, and R. Cespuglio, “Sleep structure: a new diagnostic tool for stage determination in sleeping sickness,” Acta Tropica, vol. 93, no. 1, pp. 107–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Buguet, R. Cespuglio, and B. Buguet, “Trypanosomose humaine Africaine,” in Les Troubles du Sommeil, vol. 2, chapter 33, pp. 399–406, 2012. View at Google Scholar
  34. K. G. Ghanem, R. D. Moore, A. M. Rompalo, E. J. Erbelding, J. M. Zenilman, and K. A. Gebo, “Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms,” Clinical Infectious Diseases, vol. 48, no. 6, pp. 816–821, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. F. E. McKenzie, W. A. Prudhomme, A. J. Magill et al., “White blood cell counts and malaria,” Journal of Infectious Diseases, vol. 192, no. 2, pp. 323–330, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Thwaites, M. Caws, T. T. H. Chau et al., “Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis,” Journal of Clinical Microbiology, vol. 46, no. 4, pp. 1363–1368, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Flegr and I. Stříž, “Potential immunomodulatory effects of latent toxoplasmosis in humans,” BMC Infectious Diseases, vol. 11, article 274, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. D. R. Bernardo and N. Chahin, “Toxoplasmic encephalitis during mycophenolate mofetil immunotherapy of neuromuscular disease,” Neurology: Neuroimmunology and Neuroinflammation, vol. 2, article e63, 2015. View at Google Scholar
  39. G. A. Posthuma-Trumpie, J. Korf, and A. van Amerongen, “Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey,” Analytical and Bioanalytical Chemistry, vol. 393, no. 2, pp. 569–582, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. B. O'Farrell, “Lateral flow immunoassay systems: evolution from the current state of the art to the next generation of highly sensitive, quantitative rapid assays,” in The Immunoassay Handbook: Theory and Applications of Ligand Binding, ELISA, and Related Techniques, D. Wild, Ed., pp. 89–107, Elsevier, Oxford, UK, 2013. View at Google Scholar
  41. P. Büscher, Q. Gilleman, and V. Lejon, “Rapid diagnostic test for sleeping sickness,” The New England Journal of Medicine, vol. 368, no. 11, pp. 1069–1070, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. FIND Diagnostics, The First Rapid Test to Screen for Sleeping Sickness is Launched, FIND Diagnostics, 2012.
  43. J. M. Sternberg, M. Gierliński, S. Biéler, M. A. J. Ferguson, and J. M. Ndung'u, “Evaluation of the diagnostic accuracy of prototype rapid tests for human African trypanosomiasis,” PLoS Neglected Tropical Diseases, vol. 8, no. 12, Article ID e3373, 2014. View at Publisher · View at Google Scholar
  44. L. Sullivan, S. J. Wall, M. Carrington, and M. A. J. Ferguson, “Proteomic selection of immunodiagnostic antigens for human African trypanosomiasis and generation of a prototype lateral flow immunodiagnostic device,” PLoS Neglected Tropical Diseases, vol. 7, no. 2, Article ID e2087, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Ziegelbauer, G. Multhaup, and P. Overath, “Molecular characterization of two invariant surface glycoproteins specific for the bloodstream stage of Trypanosoma brucei,” The Journal of Biological Chemistry, vol. 267, no. 15, pp. 10797–10803, 1992. View at Google Scholar · View at Scopus
  46. B. Courtioux, C. Boda, G. Vatunga et al., “A link between chemokine levels and disease severity in human African trypanosomiasis,” International Journal for Parasitology, vol. 36, no. 9, pp. 1057–1065, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Reiber and J. B. Peter, “Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs,” Journal of the Neurological Sciences, vol. 184, no. 2, pp. 101–122, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. N. Tiberti, A. Hainard, and J.-C. Sanchez, “Translation of human African trypanosomiasis biomarkers towards field application,” Translational Proteomics, vol. 1, no. 1, pp. 12–24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. B. Courtioux, L. Pervieux, G. Vatunga et al., “Increased CXCL-13 levels in human African trypanosomiasis meningo-encephalitis,” Tropical Medicine and International Health, vol. 14, no. 5, pp. 529–534, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Kristensson, M. Nygård, G. Bertini, and M. Bentivoglio, “African trypanosome infections of the nervous system: parasite entry and effects on sleep and synaptic functions,” Progress in Neurobiology, vol. 91, no. 2, pp. 152–171, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Tiberti, A. Hainard, V. Lejon et al., “Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness,” PLoS ONE, vol. 7, no. 7, Article ID e40909, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Tiberti, E. Matovu, A. Hainard et al., “New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients,” Clinical and Translational Medicine, vol. 2, article 1, 2013. View at Publisher · View at Google Scholar
  53. S. Bührer-Sekula, F. F. V. Hamerlinck, T. A. Out, L. G. Bordewijk, and P. R. Klatser, “Simple dipstick assay for semi-quantitative detection of neopterin in sera,” Journal of Immunological Methods, vol. 238, no. 1-2, pp. 55–58, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. L. MacLean, M. Odiit, and J. M. Sternberg, “Intrathecal cytokine responses in Trypanosoma brucei rhodesiense sleeping sickness patients,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 100, no. 3, pp. 270–275, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. X. Yuan and D. M. Desiderio, “Proteomics analysis of human cerebrospinal fluid,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 815, no. 1-2, pp. 179–189, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Hainard, N. Tiberti, X. Robin et al., “A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients,” PLoS Neglected Tropical Diseases, vol. 3, no. 6, article e459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. L. MacLean, H. Reiber, P. G. E. Kennedy, and J. M. Sternberg, “Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response,” PLoS Neglected Tropical Diseases, vol. 6, no. 10, Article ID e1857, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. N. Tiberti, A. Hainard, V. Lejon et al., “Discovery and verification of osteopontin and beta-2-microglobulin as promising markers for staging human African trypanosomiasis,” Molecular & Cellular Proteomics, vol. 9, no. 12, pp. 2783–2795, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Geiger, G. Simo, P. Grébaut, J.-B. Peltier, G. Cuny, and P. Holzmuller, “Transcriptomics and proteomics in human African trypanosomiasis: current status and perspectives,” Journal of Proteomics, vol. 74, no. 9, pp. 1625–1643, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. Z. K. Njiru, A. S. J. Mikosza, T. Armstrong, J. C. Enyaru, J. M. Ndung'u, and A. R. C. Thompson, “Loop-mediated isothermal amplification (LAMP) method for rapid detection of Trypanosoma brucei rhodesiense,” PLoS Neglected Tropical Diseases, vol. 2, no. 2, article e147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. Z. K. Njiru, A. S. J. Mikosza, E. Matovu et al., “African trypanosomiasis: sensitive and rapid detection of the sub-genus Trypanozoon by loop-mediated isothermal amplification (LAMP) of parasite DNA,” International Journal for Parasitology, vol. 38, no. 5, pp. 589–599, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. E. Matovu, A. J. Kazibwe, C. M. Mugasa, J. M. Ndungu, and Z. K. Njiru, “Towards point-of-care diagnostic and staging tools for human African trypanosomiaisis,” Journal of Tropical Medicine, vol. 2012, Article ID 340538, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. C. M. Mugasa, G. J. Schoone, R. A. Ekangu, G. W. Lubega, P. A. Kager, and H. D. F. H. Schallig, “Detection of Trypanosoma brucei parasites in blood samples using real-time nucleic acid sequence-based amplification,” Diagnostic Microbiology and Infectious Disease, vol. 61, no. 4, pp. 440–445, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Deborggraeve and P. Büscher, “Molecular diagnostics for sleeping sickness: what is the benefit for the patient?” The Lancet Infectious Diseases, vol. 10, no. 6, pp. 433–439, 2010. View at Publisher · View at Google Scholar · View at Scopus